According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...
Add Yahoo as a preferred source to see more of our stories on Google. Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the ...
– Approval Based on Phase 3 PURPOSE 1 and PURPOSE 2 Data that Showed ≥99.9% of Participants Remained HIV Negative on Twice-Yearly Injectable Yeztugo – – Yeztugo, Nearly 20 Years in the Making, ...
(CNN) — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of ...
Lenacapavir received approval from the U.S. Food and Drug Administration (FDA) in June 2025 and has subsequently been endorsed in the updated World Health Organisation (WHO) guidelines on long-acting ...
In his State of the Nation address President Cyril Ramaphosa announced the rollout of Lenacapavir, a six-monthly HIV ...
AllAfrica on MSN
Twice-Yearly Lenacapavir Injection for HIV Prevention in Nigeria - the Real Test Is Access
On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.
Zimbabwe is preparing to make one of its boldest public‑health moves in decades - rolling out a groundbreaking HIV prevention ...
Add Yahoo as a preferred source to see more of our stories on Google. Two men, with one looking at the camera while the other looks past the other As Congress nears a January deadline to pass a ...
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® (lenacapavir)—the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results